Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,808 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07265544Recruiting
Liver disease study using advanced tissue analysis
This study uses advanced techniques to analyze liver tissue samples from people with various liver conditions. It aims to better understand how liver diseases develop and progress, which may help improve future treatments.
Guangzhou, GuangdongAges Any age - NCT07270601Recruiting
Ultrasound test for liver fat
This study is testing a new ultrasound method to measure fat in the liver. It is for people who may have a liver condition or have risk factors like diabetes or obesity, as well as healthy volunteers.
Seattle, WashingtonAges 18–75 - NCT07271927Recruiting
Light therapy for Parkinson's motor and thinking changes
This study tests whether shining light on the whole body (photobiomodulation) can help with movement and thinking problems in Parkinson's disease. It is for people in early to moderate stages who can walk independently.
Yangsan, Gyeongsangnam-doAges 40 years+ - NCT07272473Recruiting
Neck therapy for dizziness and balance in Meniere's disease
This study tests if gentle neck therapy (called cervical mobilization) can help reduce dizziness, improve balance, and help your body feel its position better. If you have Meniere’s disease and ongoing dizziness or imbalance, this treatment might add to your care routine.
Afyonkarahisar, AfyonkarahisarAges 18–60 - NCT07273721RecruitingPhase 2
Testing BT200 in type 2B von Willebrand disease
This trial tests a new medicine called BT200 (rondaptivon pegol) to see if it can safely help people with type 2B von Willebrand disease who have low platelets and recent bleeding problems.
Vienna, State of ViennaAges 18 years+ - NCT07274631Recruiting
Study of inflammatory lung diseases
This study collects information from people with various inflammatory lung conditions, like asthma or COPD, to better understand them and improve treatment. Healthy volunteers are also needed for comparison.
ReimsAges 18 years+ - NCT07275788RecruitingPhase 1
Study of REGEND003 for type 2 diabetes with kidney disease
This trial tests a new treatment, REGEND003, for people who have both type 2 diabetes and chronic kidney disease. The goal is to see if it can help manage these conditions together.
ShanghaiAges 30–75 - NCT07276087Recruiting
Physical and Mental Health in Takayasu Arteritis and Behçet's Disease
This study compares physical and mental health in people with Takayasu arteritis or Behçet's disease to healthy volunteers. It aims to better understand how these conditions affect day-to-day life and well-being.
Denizli, DenizliAges 18 years+ - NCT07279649Recruiting
Studying a stent for blood vessel disease
This study is tracking how well a specific stent (GORE® VIABAHN® VBX) works over time in people who need treatment for narrowed or blocked blood vessels. It aims to see if the stent helps keep blood flowing long-term.
MunichAges 18 years+ - NCT07279740RecruitingPhase 2
Brain stimulation plus medication for apathy in dementia
This study tests if combining a type of brain stimulation (repetitive TMS) with a medication (methylphenidate, commonly used for ADHD) can improve apathy in people with dementia. If you have Alzheimer's or mixed dementia and struggle with low motivation, this trial may help you.
Toronto, OntarioAges Any age - NCT07280546Recruiting
Breath sounds study during surgery
This trial studies breath sounds during planned surgeries under general anesthesia. It aims to understand how breath sounds change during procedures, which may help doctors improve monitoring and care.
TaipeiAges 20 years+ - NCT07281755Recruiting
Wearable sensors to predict falls in Parkinson's
This study uses small wearable sensors to measure how you walk and move. The goal is to better track Parkinson's symptoms and predict falls, so your care can be more personalized.
Newcastle upon TyneAges 50 years+ - NCT07281794Recruiting
Testing a wearable system for walking and balance in Parkinson's
This study tests a wearable system (DANU Sports) that measures how you walk and keep your balance. It aims to see if the system can help people with Parkinson's disease track their movement problems.
Newcastle upon Tyne, Tyne and WearAges 50 years+ - NCT07283081Recruiting
Nailfold capillaroscopy for new interstitial pneumonia diagnosis
This trial tests if a special microscope exam of your nailfold blood vessels (capillaroscopy) can help doctors better understand new cases of interstitial pneumonia. It may help identify underlying conditions without starting certain treatments first.
BordeauxAges 18 years+ - NCT07283289Recruiting
Obstructive sleep apnea in patients with PAD
This study looks at how common obstructive sleep apnea is in people with peripheral artery disease (PAD). Participants will have a sleep test as part of their regular care.
Toulon, VarAges 18 years+ - NCT07283822RecruitingPhase 2
Pembrolizumab and Ruxolitinib for Lymphoma
This trial is testing two drugs, pembrolizumab and ruxolitinib, together for people with certain types of lymphoma that have come back or not responded to at least one prior treatment. The goal is to see if this combination can help control the lymphoma.
New York, New YorkAges 18–95 - NCT07284641RecruitingPhase 2
Stem cell transplant for immune disorders
This trial tests a stem cell transplant to treat common variable immunodeficiency (CVID) and other immune problems. It aims to replace a faulty immune system with a healthy one from a donor.
Pittsburgh, PennsylvaniaAges 5–40 - NCT07284797RecruitingPhase 1
Safety study for autoimmune disease and healthy volunteers
This trial is testing an experimental drug for safety in people with certain autoimmune diseases—like myositis, scleroderma, or Sjögren's disease—as well as in healthy volunteers. It aims to find out if the drug is safe enough to study further.
MelbourneAges 18–75 - NCT07284823Recruiting
Cionic sleeve study for walking problems in Parkinson's
This trial tests a wearable sleeve that uses gentle electrical signals to help improve walking in people with Parkinson's disease. It aims to see if the sleeve is safe and easy to use.
Carlsbad, CaliforniaAges 22–75 - NCT07286656RecruitingPhase 1
A study of GensSci098 for Graves' disease
This study tests a new investigational drug called GensSci098 for people with Graves' disease who have not taken antithyroid medication recently. It aims to see if the drug can help manage thyroid hormone levels.
Shenyang, LiaoningAges 18 years+ - NCT07287007Recruiting
Testing a new leg compression device for blood flow
This study tests a new leg compression device called VenAir to see how well it helps blood flow. It is for healthy adults who do not have any heart or circulation problems, and who have not had blood clots or strokes in the past.
New Taipei CityAges 20–64 - NCT07288905Recruiting
Exercise with blood flow restriction for healthy people and CKD patients
This study tests if combining exercise with blood flow restriction training (BFRT) is safe and helpful for healthy adults and people with chronic kidney disease (CKD). It aims to improve strength and health without heavy weights.
TainanAges 20–85 - NCT07289620Recruiting
Nerve block boosters for kids' leg surgery
This study tests whether adding dexamethasone, dexmedetomidine, or both to a numbing shot (nerve block) provides better pain relief after leg surgery in children. The goal is to find which combination works best to keep your child comfortable with fewer side effects.
PoznanAges 3–12 - NCT07292012RecruitingPhase 4
Mirikizumab to heal intestinal damage in Crohn's disease
This trial tests if mirikizumab can reduce deep inflammation in the intestine walls in people with active Crohn's disease. It may help heal damage that shows up on an MRI scan.
BrestAges 18–75
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,808 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.